These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 33459490)
21. Universal protocol and standard-spiking strategy for profiling of host cell proteins in therapeutic growth hormone. Liu F; Ren W; Liu H; Liu H; Wang S; Zhang D; Sun D; Zhang F; Shao Z; Feng J; Yan M; Yang L; Wang Z; Zhang J; Wang Y Anal Biochem; 2023 Jun; 670():115136. PubMed ID: 37028780 [TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of CHO host-cell proteins in monoclonal antibody bioprocessing. Oh YH; Mendola KM; Choe LH; Min L; Lavoie AR; Sripada SA; Williams TI; Lee KH; Yigzaw Y; Seay A; Bill J; Li X; Roush DJ; Cramer SM; Menegatti S; Lenhoff AM Biotechnol Bioeng; 2024 Jan; 121(1):291-305. PubMed ID: 37877536 [TBL] [Abstract][Full Text] [Related]
23. Enhanced Detection of Low-Abundance Host Cell Protein Impurities in High-Purity Monoclonal Antibodies Down to 1 ppm Using Ion Mobility Mass Spectrometry Coupled with Multidimensional Liquid Chromatography. Doneanu CE; Anderson M; Williams BJ; Lauber MA; Chakraborty A; Chen W Anal Chem; 2015 Oct; 87(20):10283-91. PubMed ID: 26266576 [TBL] [Abstract][Full Text] [Related]
24. Host cell protein networks as a novel co-elution mechanism during protein A chromatography. Panikulam S; Hanke A; Kroener F; Karle A; Anderka O; Villiger TK; Lebesgue N Biotechnol Bioeng; 2024 May; 121(5):1716-1728. PubMed ID: 38454640 [TBL] [Abstract][Full Text] [Related]
25. More similar than different: Host cell protein production using three null CHO cell lines. Yuk IH; Nishihara J; Walker D; Huang E; Gunawan F; Subramanian J; Pynn AF; Yu XC; Zhu-Shimoni J; Vanderlaan M; Krawitz DC Biotechnol Bioeng; 2015 Oct; 112(10):2068-83. PubMed ID: 25894672 [TBL] [Abstract][Full Text] [Related]
27. Versatile LC-MS-Based Workflow with Robust 0.1 ppm Sensitivity for Identifying Residual HCPs in Biotherapeutic Products. Yang F; Li D; Kufer R; Cadang L; Zhang J; Dai L; Guo J; Wohlrab S; Greenwood-Goodwin M; Shen A; Duan D; Li H; Yuk IH Anal Chem; 2022 Jan; 94(2):723-731. PubMed ID: 34927411 [TBL] [Abstract][Full Text] [Related]
28. Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics. Jawa V; Joubert MK; Zhang Q; Deshpande M; Hapuarachchi S; Hall MP; Flynn GC AAPS J; 2016 Nov; 18(6):1439-1452. PubMed ID: 27450229 [TBL] [Abstract][Full Text] [Related]
29. SP3-based host cell protein monitoring in AAV-based gene therapy products using LC-MS/MS. Smith J; Strasser L; Guapo F; Milian SG; Snyder RO; Bones J Eur J Pharm Biopharm; 2023 Aug; 189():276-280. PubMed ID: 37419424 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive assessment of host cell protein expression after extended culture and bioreactor production of CHO cell lines. Hamaker NK; Min L; Lee KH Biotechnol Bioeng; 2022 Aug; 119(8):2221-2238. PubMed ID: 35508759 [TBL] [Abstract][Full Text] [Related]
31. Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development. Molden R; Hu M; Yen E S; Saggese D; Reilly J; Mattila J; Qiu H; Chen G; Bak H; Li N MAbs; 2021; 13(1):1955811. PubMed ID: 34365906 [TBL] [Abstract][Full Text] [Related]
32. Quantitative host cell protein analysis using two dimensional data independent LC-MS(E). Farrell A; Mittermayr S; Morrissey B; Mc Loughlin N; Navas Iglesias N; Marison IW; Bones J Anal Chem; 2015 Sep; 87(18):9186-93. PubMed ID: 26280711 [TBL] [Abstract][Full Text] [Related]
33. Host cell protein testing strategy for hepatitis B antigen in Hexavalent vaccine - Towards a general testing strategy for recombinant vaccines. Biologicals; ; . PubMed ID: 29861269 [TBL] [Abstract][Full Text] [Related]